Zhi-gong Wei, Hui-jiao Chen, De-juan Wang, Zheng Jiang, Yi-yan Pei, Le-yu Li, Feng Wang, Jing Jin, Zhe-ran Liu, Fei Chen, Jun Liu, Xing-chen Peng. "Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial." Nature Communications, 2025. doi:10.1038/s41467-025-63978-y